1. Market News
Cadila Healthcare stock price gained over 4% during the day before closing at Rs 377.60 after its Chairman Pankaj Patel announced that they aim to complete late-stage trials for its coronavirus vaccine candidate ‘ZyCov-D’ by March 2021. Cadila will start production of 100 million doses of potential Covid19 vaccine annually after Phase 3 trial concludes […]